Keywords
MedicineDiabetes mellitusGlycemicContext (archaeology)Type 2 diabetesInternal medicineDiseaseIntensive care medicineEndocrinology
Related Publications
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
Uncertainty persists concerning the effect of improved long-term glycemic control on macrovascular disease in diabetes mellitus (DM). We performed a systematic review and meta-a...
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
OBJECTIVE The Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial reported that intensive glucose control prevents end-stage...
The Metabolic Syndrome: Time for a Critical Appraisal
The term “metabolic syndrome” refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin r...
Standards of Medical Care in Diabetes—2007
Cardiovascular disease 1. Hypertension/blood pressure control 2. Dyslipidemia/lipid management 3. Antiplatelet agents 4. Smoking cessation 5. C o r o n a r y h e a r t d i s e a...
Publication Info
- Year
- 2007
- Type
- article
- Volume
- 99
- Issue
- 12
- Pages
- S21-S33
- Citations
- 635
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
635
OpenAlex
Cite This
John B. Buse
(2007).
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods.
The American Journal of Cardiology
, 99
(12)
, S21-S33.
https://doi.org/10.1016/j.amjcard.2007.03.003
Identifiers
- DOI
- 10.1016/j.amjcard.2007.03.003